At a glance
ClinicalIndex Comparison RecordN/ACompleted· 141 enrolled
Drug / intervention
Thermal Anisotropy Measurement Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device, Phase B
In Brief
An observational study evaluating Thermal Anisotropy Measurement Device for Hydrocephalus. Completed, enrolled 141 participants across 10 sites.
Detailed Summary
This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHydrocephalus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartJul 2022
Primary CompletionNov 2023
Study CompletionNov 2023
TodayJul 2026
First PostedJun 27, 2022
Enrollment StartJul 7, 2022
Primary CompletionNov 3, 2023
Study CompletionNov 10, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.0 years ago
Interventions
Thermal Anisotropy Measurement Devicedevice
A wireless device for non-invasively assessing CSF shunt flow.